Search results
You searched for:
Found 2,284 results
Sorting options:
Date: 01/01/2023 Location: Other
This webinar is the fourth in a four-part series on ESUS and the importance of patent foramen ovale in ESUS aetiology and management. This activity will use an interactive panel conversation to explore the following via a case study: · How does ESUS shift the thinking for post stroke discharge back to general practiceo Do all my stroke patients have a cause for stroke outlined in the discharge summary?o What is the role of the GP in ensuring a stroke work up is completed?o What about our rural and remote patients? · Lifestyle/post-procedural management o MRI safety o Medication management o AF risk o Do PFOs need to be surveilled with echocardiograms after insertion? · Secondary prevention guidelines o Are oestrogens CI in ESUS patients? o What is the stroke risk after PFO closure? o Do PFOs run in families (e.g.: does this have any implication for risk in family members?) o Do ESUS patients have the same stroke rehabilitation requirements as other stroke patients? andlt;grammarly-desktop-integration data-grammarly-shadow-root="true"andgt;andlt;/grammarly-desktop-integrationandgt;
1 Educational activity hour
Date: 01/01/2023 Location: Other
This medicinal cannabis course focuses on the history of cannabis and medical acceptance. The course considers the cannabis plant and its colourful history as a psychotropic agent, a commodity, a sacred entity and a medicine to treat a raft of disorders. Maligned and criminalised in the second half of the 20th century, medicinal cannabis is now in a new cycle with a burgeoning and sustained scientific interest in its potential medical uses. Cannabinoid chemistry and EndoCB signalling in cells are discussed and supported with diagrams. The legalisation of medicinal cannabis across some countries and World Health Oganisation (WHO) recommendations are included. The course concludes with medicinal cannabis safety considerations.
4 Educational activity hours
5 Performance review hours
Culturally safe practice
Addressing health inequities
Professionalism
Ethical practice
Date: 01/01/2023 Location: Other
This medicinal cannabis course focuses on the introduction to the endocannabinoid system. The course analyses the homeostatic endocannabinoid system and its broad scope of influence in both health and disease. The endocannabinoid system’s three central instruments are established, the endocannabinoids, receptors, and enzymes, followed by an analysis of the system’s homeostatic functions, including analgesia, mood, energy balance, and stress coping. Evidence for the relationship between insufficiency or dysregulation of the endocannabinoid system and particular disorders is also discussed. Finally, the course provides an overview of our current understanding of cannabinoids, such as THC and CBD, and how ongoing research into targeted manipulation of the endocannabinoid system with active cannabinergic compounds may prove therapeutic in numerous pathological conditions.
4 Educational activity hours
5 Performance review hours
Culturally safe practice
Addressing health inequities
Professionalism
Ethical practice
Date: 01/01/2023 Location: Other
This medicinal cannabis course focuses on the major phytocannabinoids: THC and CBD. The course provides a comprehensive examination of the two main cannabinoids, tetrahydrocannabinol (THC) and cannabidiol (CBD). It distinguishes between their main actions and analyses their synergistic relationship. Chemical structures and how they work are explained. Various trial results are discussed and safety guides discussed. Given that THC and CBD interact differently within the endocannabinoid system and with other neurotransmitters, the course considers their different therapeutic potential.
4 Educational activity hours
5 Performance review hours
Culturally safe practice
Addressing health inequities
Professionalism
Ethical practice
Date: 02/01/2023 Location: Other
This learning module consists of approximately 2 hours of online active learning and self-assessment focused on how general practitioners (GPs) and PNs and other primary care providers can operate under the Victorian Government's information sharing schemes for providers in contact with people experiencing or using family violence. This includes the Family Violence Information Sharing Scheme (FVISS) and the Child Information Sharing Scheme (CISS) which are underpinned by the Multi Agency Risk assessment and Management Framework (MARAM). We outline what the Information Sharing Schemes and MARAM aim to achieve and how you can use them to work across the services system to consistently and sensitively identify and respond to family violence and manage risk. This includes what to do when a patient discloses to enable a best practice response and referral. Incorporating examples of real case studies and role plays, and reflective questions, we have aimed to make this course as interactive as possible.
2 Educational activity hours
Date: 01/01/2023 Location: Other
This medicinal cannabis course focuses on routes of administration, side effects and contra indications. The course discusses the safe use of medicinal cannabis, outlining the routes of administration, side effects, and contraindications. Cannabinoid pharmacokinetics are also examined, including its absorption following diverse administration routes, metabolism by different tissues and organs, bioavailability and elimination from the body. Despite its extreme safety as a medication generally and particularly relative to opioids, potential adverse effects and contrindicaitons of cannabis are outlined. The course also analyses the potential for drug-to-drug interaction given CBD and THC’s effects on common biological pathways implicated in drug metabolism via their interactions with cytochrome P450 enzymes specifically.
4 Educational activity hours
6 Performance review hours
Culturally safe practice
Addressing health inequities
Professionalism
Ethical practice
Date: 01/01/2023 Location: Other
This medicinal cannabis course focuses on patient cases and basic ailments. The course identifies a number of basic ailments that may be successfully treated with medical cannabis in General Practice. For example, the adverse effects of cancer treatment, the symptoms of chronic pain, anxiety, depression, and insomnia could be alleviated by medicinal cannabis with mild side effects and minimal risk of toxicity or addiction. Providing that conventional treatments have failed or caused unacceptable side effects, a growing number of conditions lend themselves to treatment with cannabis. Given the complex chemical profile, there is a single medication potential to assist with multiple symptoms, thereby reducing polypharmacy. The course applies an individualised management plan to three comprehensive case studies for patients with chronic pain, osteoarthritis, and anxiety and depression. Considerations ranging from the cost to the patient to the appropriate THC to CBD ratio are addressed. Finally, the course guides the practitioner in navigating an application for a TGA Special Access Scheme/SAS B.
4.5 Educational activity hours
6 Performance review hours
Culturally safe practice
Addressing health inequities
Professionalism
Ethical practice
Date: 01/01/2023 Location: Other
This medicinal cannabis course focuses on using medicinal cannabis for managing chronic pain. The course discusses the use of medicinal cannabis as an emerging option for clinicians to reduce and alleviate difficult-to-treat, chronic, neuropathic pain. It includes analyses of the endocannabinoid system and the diverse, multimodal mechanisms of cannabinoid-induced analgesia. THC and CBD are an excellent additive treatment to concurrent conventional pain management for many chronic pain types associated with a range of diseases such as fibromyalgia, traumatic injury, and multiple sclerosis. For patients suffering from neuropathic pain, cannabinoids may be used successfully as an adjunctive, opioid-sparing, or ultimately a replacement therapy for managing their pain. The course also discusses a management plan’s necessary considerations such as determining dosages and accounting for safety considerations, and applies these protocols to a chronic pain case study.
4 Educational activity hours
6 Performance review hours
Culturally safe practice
Addressing health inequities
Professionalism
Ethical practice
Date: 01/01/2023 Location: Other
This medicinal cannabis course focuses on anxiety, insomnia and depression. The course examines the homeostatic functions of the endocannabinoid system in relation to mood, stress response, and sleep. It also evaluates the therapeutic capacity of the major cannabinoids (THC and CBD), in isolation and in synergy, in relation to anxiety, depression, and insomnia. In developing a treatment plan, essential factors such as the interplay between depression, anxiety, pain, and insomnia are considered, as well as protocols for THC to CBD ratios in basic dosing, and the route and timing of administration with reference to each condition. With regard to treating insomnia particularly, the course addresses the role of other lesser-known cannabinoids, such as CBN, and terpenes. Pertinent considerations such as the dampening effect of CBD upon the undesirable effects of THC such as intoxication, tachycardia and psycho-activity (particularly important when treating anxiety) are also discussed.
4 Educational activity hours
6 Performance review hours
Culturally safe practice
Addressing health inequities
Professionalism
Ethical practice
Date: 01/01/2023 Location: Other
This medicinal cannabis course focuses on cancer symptomatic treatment. The course reviews the myriad of functions of cannabinoids and the endocannabinoid system and considers the supportive role they may have to play in cancer therapy. Although research continues into the anti-tumour properties of cannabinoids, there is currently no evidence that medical cannabis can cure or even treat cancer. Nonetheless, it can be a successful additional therapy used in the management of cancer symptoms and the iatrogenic effects of treatment. The judicious use of medicinal cannabis can significantly improve cancer sufferers’ quality of life by managing persistent symptoms and side effects such as, cancer pain, nausea, vomiting, and chemotherapy-induced nausea and vomiting. The course also considers the case studies of three different cancer patients and, for each, examines issues for the clinician related to assessment, dosing recommendations, formulation, methods of administration, and side effects.
4 Educational activity hours
6 Performance review hours
Culturally safe practice
Addressing health inequities
Professionalism
Ethical practice